Remove Diagnose Remove Diagnostic Remove Disease Remove Events
article thumbnail

Dartmouth event bats around promise, shortcomings of AI in healthcare

AuntMinnie

Langlotz's laboratory investigates the use of deep neural networks and other machine-learning technologies to detect disease and eliminate diagnostic errors through analysis of medical images and clinical notes. Photo courtesy of Dartmouth.

article thumbnail

Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting

Imaging Technology

Chief Executive Officer of Blue Earth Diagnostics. Blue Earth Diagnostics will also host an Industry-Expert Theater event, ‘POSLUMA: Precision PET Imaging that is Truly Revealing’.” PET in Men with Newly Diagnosed High-risk Prostate Cancer and Negative Conventional Imaging Presenter: Phillip H. Gauden , D.Phil.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

Imaging Technology

Specifically, this sub-group examined the performance of flotufolastat F 18 PET in newly diagnosed, high-risk prostate cancer patients who had negative results with conventional imaging. Such information can help guide treatment selection and potentially avoid futile surgery for patients with high-risk disease.” “We Gauden, D.Phil.

article thumbnail

Can MRI Diagnose Dementia?

The Radiology Clinic

Can MRI diagnose dementia? The truth is that MRI is NOT the test to formally diagnose dementia. The truth is that MRI is NOT the test to formally diagnose dementia. Alzheimer’s disease is the most common and well known rendition of dementia, but there are other forms of the disease as well.

article thumbnail

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

Imaging Technology

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. Chief Executive Officer of Blue Earth Diagnostics. Gauden , D.Phil., The adverse reactions reported in ≥0.4%

article thumbnail

CT may be preferred over ICA for younger cardiac patients

AuntMinnie

A team led by the DISCHARGE Trial Group found that while age does change the effect of CT and invasive coronary angiography (ICA) on the outcome of major adverse cardiovascular events (MACE), it does modify the effect of these techniques on major procedure-related complications.

Disease 122
article thumbnail

Study: Ditch the contrast agent in PET/MRI scans in children with lymphoma

AuntMinnie

In a scientific session held November 30, Nils-Martin Bruckmann, MD, of University Hospital Düsseldorf in Germany, discussed a study that evaluated FDG-PET/MRI scans with and without the use of a contrast agent in children with newly diagnosed disease. The study authors found the contrast agent made no diagnostic difference.

MRI 111